Drug firm Eris Lifesciences today reported a 10.06 per cent rise in its consolidated net profit to Rs 74.92 crore for the quarter ended December 2017.
The company had posted a net profit of Rs 68.07 crore for the corresponding period of the previous fiscal, Eris Lifesciences said in a BSE filing.
Consolidated total income of the company also rose to Rs 214.75 crore for the quarter under consideration as against Rs 190 crore in the same period a year ago.
Shares of Eris Lifesciences closed 0.35 per cent higher at Rs 765.05 per scrip on BSE today.
Disclaimer: No Business Standard Journalist was involved in creation of this content
